- Home
- PACB vs OLMA Comparison
PACB vs OLMA Comparison
Compare PACB & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PACB
- OLMA
- Stock Information
- Founded
- PACB 2000
- OLMA 2006
- Country
- PACB United States
- OLMA United States
- Employees
- PACB N/A
- OLMA N/A
- Industry
- PACB Biotechnology: Laboratory Analytical Instruments
- OLMA Biotechnology: Pharmaceutical Preparations
- Sector
- PACB Industrials
- OLMA Health Care
- Exchange
- PACB Nasdaq
- OLMA Nasdaq
- Market Cap
- PACB 364.2M
- OLMA 299.7M
- IPO Year
- PACB 2010
- OLMA 2020
- Fundamental
- Price
- PACB $1.57
- OLMA $4.57
- Analyst Decision
- PACB Buy
- OLMA Strong Buy
- Analyst Count
- PACB 9
- OLMA 4
- Target Price
- PACB $2.06
- OLMA $24.50
- AVG Volume (30 Days)
- PACB 11.0M
- OLMA 962.9K
- Earning Date
- PACB 08-06-2025
- OLMA 08-05-2025
- Dividend Yield
- PACB N/A
- OLMA N/A
- EPS Growth
- PACB N/A
- OLMA N/A
- EPS
- PACB N/A
- OLMA N/A
- Revenue
- PACB $152,357,000.00
- OLMA N/A
- Revenue This Year
- PACB $3.33
- OLMA N/A
- Revenue Next Year
- PACB $18.52
- OLMA N/A
- P/E Ratio
- PACB N/A
- OLMA N/A
- Revenue Growth
- PACB N/A
- OLMA N/A
- 52 Week Low
- PACB $0.85
- OLMA $2.86
- 52 Week High
- PACB $2.72
- OLMA $16.62
- Technical
- Relative Strength Index (RSI)
- PACB 72.41
- OLMA 52.70
- Support Level
- PACB $1.20
- OLMA $4.12
- Resistance Level
- PACB $1.35
- OLMA $4.70
- Average True Range (ATR)
- PACB 0.12
- OLMA 0.31
- MACD
- PACB 0.03
- OLMA 0.04
- Stochastic Oscillator
- PACB 92.16
- OLMA 74.73
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.